<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">35413805</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>140</StartPage><MedlinePgn>140</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">140</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-022-02662-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">People with amyotrophic lateral sclerosis (ALS) are at high risk for severe outcomes from Covid-19 infection. Researchers exploring ALS and Covid-19 have focused primarily on system response and adaptation. Using Protection Motivation Theory, we investigated how people with ALS and family caregivers appraised and responded to Covid-19 threat, the 'costs' associated with pandemic response, and how health professionals and systems can better support people affected by ALS who are facing public health emergencies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data were drawn from the 'ALS Talk Project,' an asynchronous, moderated focus group study. Participants were recruited from regions across Canada. Seven groups met online over 14&#x2009;weeks between January and July 2020. Fifty-three participants contributed to Covid-19 discussions. Data were qualitatively analyzed using directed content analysis and the constant-comparative approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants learned about the Covid-19 pandemic from the media. They rapidly assessed their vulnerability and responded to Covid-19 threat by following recommendations from health authorities, information monitoring, and preparing for worst-case scenarios. Adopting protective behaviors had substantial response costs, including adaptations for medical care and home support workers, threatened access to advance care, and increased caregiver burden. Participants expressed need for ALS-specific, pandemic information from trusted health professionals and/or ALS health charities. Telemedicine introduced both conveniences and costs. Prior experience with ALS provided tools for coping with Covid-19. Threat and coping appraisal was a dynamic process involving ongoing vigilance and adaptation. Findings draw attention to the lack of emergency preparedness among participants and within health systems.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinicians should engage ALS patients and families in ongoing discussions about pandemic coping, strategies to mitigate response costs, care pathways in the event of Covid-19 infection, and changing information about Covid-19 variants and vaccines. Healthcare systems should incorporate flexible approaches for medical care, leveraging the benefits of telemedicine and facilitating in-person interaction as needed and where possible. Research is needed to identify strategies to mitigate response costs and to further explore the interaction between prior experience and coping. Further study is also needed to determine how communication about emergency preparedness might be effectively incorporated into clinical care for those with ALS and other medically vulnerable populations.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Genuis</LastName><ForeName>Shelagh K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Alberta, 7-123 Clinical Sciences Building, Edmonton, Alberta, T6G 2B7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luth</LastName><ForeName>Westerly</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Alberta, 7-123 Clinical Sciences Building, Edmonton, Alberta, T6G 2B7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bubela</LastName><ForeName>Tania</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Simon Fraser University, Blusson Hall 11328, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Wendy S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Alberta, 7-123 Clinical Sciences Building, Edmonton, Alberta, T6G 2B7, Canada. wendyj@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="N">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Covid 19</Keyword><Keyword MajorTopicYN="N">Emergency planning</Keyword><Keyword MajorTopicYN="N">Family caregivers</Keyword><Keyword MajorTopicYN="N">Pandemics</Keyword><Keyword MajorTopicYN="N">Patients</Keyword><Keyword MajorTopicYN="N">Protective motivation theory</Keyword></KeywordList><CoiStatement>All the authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35413805</ArticleId><ArticleId IdType="pmc">PMC9002218</ArticleId><ArticleId IdType="doi">10.1186/s12883-022-02662-w</ArticleId><ArticleId IdType="pii">10.1186/s12883-022-02662-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Bio Medica Atenei Parm. 2020;91:157&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19: A Canadian timeline | Canadian Healthcare Network [Internet]. 2020 [cited 2021 Mar 24];Available from: https://www.canadianhealthcarenetwork.ca/covid-19-a-canadian-timeline</Citation></Reference><Reference><Citation>COVID-19: A timeline of Canada&#x2019;s first-wave response | CMAJ News [Internet]. 2020 [cited 2021 Mar 24];Available from: https://cmajnews.com/2020/06/12/coronavirus-1095847/</Citation></Reference><Reference><Citation>Lee K, Worsnop CZ, Gr&#xe9;pin KA, Kamradt-Scott A. Global coordination on cross-border travel and trade measures crucial to COVID-19 response. Lancet. 2020;395:1593&#x2013;1595. doi: 10.1016/S0140-6736(20)31032-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31032-1</ArticleId><ArticleId IdType="pmc">PMC7255339</ArticleId><ArticleId IdType="pubmed">32416788</ArticleId></ArticleIdList></Reference><Reference><Citation>Han E, Tan MMJ, Turk E, Sridhar D, Leung GM, Shibuya K, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525&#x2013;1534. doi: 10.1016/S0140-6736(20)32007-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32007-9</ArticleId><ArticleId IdType="pmc">PMC7515628</ArticleId><ArticleId IdType="pubmed">32979936</ArticleId></ArticleIdList></Reference><Reference><Citation>Advice for the public on COVID-19 &#x2013; World Health Organization [Internet]. [cited 2021 Mar 30];Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public</Citation></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primer. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2009;10:310&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis. Neurol Clin Pract. 2013;3:313&#x2013;320. doi: 10.1212/CPJ.0b013e3182a1b8ab.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0b013e3182a1b8ab</ArticleId><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertran Recasens B, Rubio MA. Neuromuscular Diseases Care in the Era of COVID-19. Front Neurol. 2020;11 [cited 2021 Mar 29]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732578/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732578</ArticleId><ArticleId IdType="pubmed">33329336</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Telesca A, Dalla Bella E, Bersano E, Lauria G. Amyotrophic lateral sclerosis patients&#x2019; and caregivers&#x2019; distress and loneliness during COVID-19 lockdown. J Neurol. 2020[cited 2021 Jan 6]. 10.1007/s00415-020-10080-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7372539</ArticleId><ArticleId IdType="pubmed">32696342</ArticleId></ArticleIdList></Reference><Reference><Citation>Digala LP, Prasanna S, Rao P, Govindarajan R, Qureshi AI. Impact of COVID- 19 Infection Among Hospitalized Amyotrophic Lateral Sclerosis Patients. J Clin Neuromuscul Dis. 2021;22:180&#x2013;181. doi: 10.1097/CND.0000000000000335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CND.0000000000000335</ArticleId><ArticleId IdType="pmc">PMC7892201</ArticleId><ArticleId IdType="pubmed">33596004</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities. Muscle Nerve. 2020;62:182&#x2013;186. doi: 10.1002/mus.26989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26989</ArticleId><ArticleId IdType="pmc">PMC7283687</ArticleId><ArticleId IdType="pubmed">32445195</ArticleId></ArticleIdList></Reference><Reference><Citation>Burchill E, Rawji V, Styles K, Rooney S, Stone P, Astin R, et al. When months matter; modelling the impact of the COVID-19 pandemic on the diagnostic pathway of Motor Neurone Disease (MND). medRxiv. 2020. [cited 2022 April 11]. Available from: https://www.medrxiv.org/content/10.1101/2020.12.22.20248666v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.22.20248666v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris SP, Likanje M-FN, Andrews JA. Amyotrophic lateral sclerosis: update on clinical management. [Review] Curr Opin Neurol. 2020;33:641&#x2013;648. doi: 10.1097/WCO.0000000000000864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000864</ArticleId><ArticleId IdType="pubmed">32868602</ArticleId></ArticleIdList></Reference><Reference><Citation>Esselin F, Cruz EDL, Pageot N, Juntas-Moral&#xe8;s R, Alphand&#xe9;ry S, Camu W. Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France. Amyotroph Lateral Scler Front Degener. 2021;0:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">33576710</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabona C, Ferraro PM, Meo G, Roccatagliata L, Schenone A, Inglese M, et al. Predictors of self-perceived health worsening over COVID-19 emergency in ALS. Neurol Sci. 2021;1&#x2013;6. [cited 2022 April 11]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807220/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7807220</ArticleId><ArticleId IdType="pubmed">33443667</ArticleId></ArticleIdList></Reference><Reference><Citation>Capozzo R, Zoccolella S, Musio M, Barone R, Accogli M, Logroscino G. Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy. Amyotroph Lateral Scler Front Degener. 2020;21:542&#x2013;548. doi: 10.1080/21678421.2020.1773502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1773502</ArticleId><ArticleId IdType="pubmed">32530314</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Cantello R, Ambrosini S, Mazzini L, Sarnelli MF, De Marchi I, et al. Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurol Sci. 2020;41:1365&#x2013;1367. doi: 10.1007/s10072-020-04457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04457-8</ArticleId><ArticleId IdType="pmc">PMC7240164</ArticleId><ArticleId IdType="pubmed">32440978</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Sarnelli MF, Serioli M, De Marchi I, Zani E, Bottone N, et al. Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID-19 pandemic. Acta Neurol Scand. 2020. [cited 2022 April 11]. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ane.13373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13373</ArticleId><ArticleId IdType="pubmed">33185886</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Quintarelli S, Silani V. New technologies and Amyotrophic Lateral Sclerosis &#x2013; Which step forward rushed by the COVID-19 pandemic? J Neurol Sci. 2020;418:117081. doi: 10.1016/j.jns.2020.117081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117081</ArticleId><ArticleId IdType="pmc">PMC7403097</ArticleId><ArticleId IdType="pubmed">32882437</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R, Moglia C, D&#x2019;Ovidio F, Pede FD, Mattei FD, Cabras S, et al. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotroph Lateral Scler Front Degener. 2020;0:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32924624</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu D, Berry JD, Paganoni S, Glass JD, Fournier C, Cuerdo J, et al. Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic. Amyotroph Lateral Scler Front Degener. 2021;22:22&#x2013;32. doi: 10.1080/21678421.2021.1924207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1924207</ArticleId><ArticleId IdType="pubmed">34348539</ArticleId></ArticleIdList></Reference><Reference><Citation>Govindarajan R, Berry JD, Paganoni S, Pulley MT, Simmons Z. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle Nerve. 2020;62:321&#x2013;326. doi: 10.1002/mus.26921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26921</ArticleId><ArticleId IdType="pubmed">32415876</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera U, Cabras S, Daviddi M, Vasta R, Torrieri MC, Palumbo F, et al. Validation of the Italian version of self-administered ALSFRS-R scale. Amyotroph Lateral Scler Front Degener. 2020;0:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32856494</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar S, Abdul-Aziz NA, Loh EC, Capelle D, Goh K-J, Latif LA, et al. A survey on patients&#x2019; disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in Malaysia. Neurodegener Dis Manag. 2021. 10.2217/nmt-2021-0004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320654</ArticleId><ArticleId IdType="pubmed">34284643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagihashi M, Sugisawa T, Fuchimoto M, Saotome Y, Onozawa K, Matsumoto Y, et al. Contradictory Responses to the COVID-19 Pandemic in Amyotrophic Lateral Sclerosis Patients and Their Families and Caregivers in Japan. Intern Med. 2021;60:1519&#x2013;1524. doi: 10.2169/internalmedicine.6810-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.6810-20</ArticleId><ArticleId IdType="pmc">PMC8188022</ArticleId><ArticleId IdType="pubmed">33994445</ArticleId></ArticleIdList></Reference><Reference><Citation>Weston D, Ip A, Aml&#xf4;t R. Examining the application of behaviour change theories in the context of infectious disease outbreaks and emergency response: a review of reviews. BMC Public Health. 2020;20:1483. doi: 10.1186/s12889-020-09519-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09519-2</ArticleId><ArticleId IdType="pmc">PMC7528712</ArticleId><ArticleId IdType="pubmed">33004011</ArticleId></ArticleIdList></Reference><Reference><Citation>Floyd DL, Prentice-Dunn S, Rogers RW. A Meta-Analysis of Research on Protection Motivation Theory. J Appl Soc Psychol. 2000;30:407&#x2013;429. doi: 10.1111/j.1559-1816.2000.tb02323.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1559-1816.2000.tb02323.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Prentice-Dunn S, Rogers RW. Protection Motivation Theory and preventive health: beyond the Health Belief Model. Health Educ Res. 1986;1:153&#x2013;161. doi: 10.1093/her/1.3.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/her/1.3.153</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers RW. A Protection Motivation Theory of Fear Appeals and Attitude Change. Aust J Psychol. 1975;91:93&#x2013;114. doi: 10.1080/00223980.1975.9915803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00223980.1975.9915803</ArticleId><ArticleId IdType="pubmed">28136248</ArticleId></ArticleIdList></Reference><Reference><Citation>Adunlin G, Adedoyin ACA, Adedoyin OO, Njoku A, Bolade-Ogunfodun Y, Bolaji B. Using the protection motivation theory to examine the effects of fear arousal on the practice of social distancing during the COVID-19 outbreak in rural areas. J Hum Behav Soc Environ. 2020;0:1&#x2013;5.</Citation></Reference><Reference><Citation>Al-Rasheed M. Protective Behavior against COVID-19 among the Public in Kuwait: An Examination of the Protection Motivation Theory, Trust in Government, and Sociodemographic Factors. Soc Work Public Health. 2020;35:546&#x2013;556. doi: 10.1080/19371918.2020.1806171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19371918.2020.1806171</ArticleId><ArticleId IdType="pubmed">32970542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhati AS, Mohammadi Z, Agarwal M, Kamble Z, Donough-Tan G. Motivating or manipulating: the influence of health-protective behaviour and media engagement on post-COVID-19 travel. Curr Issue Tour. 2021;24:2088&#x2013;2092. doi: 10.1080/13683500.2020.1819970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13683500.2020.1819970</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezati Rad R, Mohseni S, Kamalzadeh Takhti H, Hassani Azad M, Shahabi N, Aghamolaei T, et al. Application of the protection motivation theory for predicting COVID-19 preventive behaviors in Hormozgan, Iran: a cross-sectional study. BMC Public Health. 2021;21:466. doi: 10.1186/s12889-021-10500-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-10500-w</ArticleId><ArticleId IdType="pmc">PMC7938277</ArticleId><ArticleId IdType="pubmed">33685426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalski RM, Black KJ. Protection Motivation and the COVID-19 Virus. Health Commun. 2021;36:15&#x2013;22. doi: 10.1080/10410236.2020.1847448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10410236.2020.1847448</ArticleId><ArticleId IdType="pubmed">33190547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Kunasekaran P, Rasoolimanesh SM. What influences people&#x2019;s willingness to receive the COVID-19 vaccine for international travel? Curr Issue Tour. 2021;0:1&#x2013;6.</Citation></Reference><Reference><Citation>Yazdanpanah M, Abadi B, Komendantova N, Zobeidi T, Sieber S. Some at Risk for COVID-19 Are Reluctant to Take Precautions, but Others Are Not: A Case From Rural in Southern Iran. Front Public Health. 2020;8 [cited 2021 Jan 6]. Available from: https://www.frontiersin.org/articles/10.3389/fpubh.2020.562300/full.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.562300/full</ArticleId><ArticleId IdType="pmc">PMC7701237</ArticleId><ArticleId IdType="pubmed">33304873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgkinson V, Lounsberry J, M&#x2019;Dahoma S, Russell A, Jewett G, Benstead T, et al. The Canadian Neuromuscular Disease Registry 2010&#x2013;2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-Neuromuscular Disease Registry. J Neuromuscul Dis. 2021;8:53&#x2013;61. doi: 10.3233/JND-200538.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-200538</ArticleId><ArticleId IdType="pmc">PMC7902956</ArticleId><ArticleId IdType="pubmed">32925088</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams K, Gaiser T. Online Focus Groups. In: Fielding N, Lee R, Blank G, editors. The SAGE Handbook of Online Research Methods. London: SAGE Publications, Ltd; 2017. pp. 290&#x2013;306.</Citation></Reference><Reference><Citation>Gordon AR, Calzo JP, Eiduson R, Sharp K, Silverstein S, Lopez E, et al. Asynchronous Online Focus Groups for Health Research: Case Study and Lessons Learned. Int J Qual Methods. 2021;20:1609406921990489. doi: 10.1177/1609406921990489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1609406921990489</ArticleId><ArticleId IdType="pmc">PMC8856649</ArticleId><ArticleId IdType="pubmed">35185443</ArticleId></ArticleIdList></Reference><Reference><Citation>Boateng B, Nelson MK. Online Focus Groups with Parents And Adolescents with Heart Transplants: Challenges and Opportunities. Pediatr Nurs. 2016;42:120&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">27468513</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron J, Light J. &#x201c;My World Has Expanded Even Though I&#x2019;m Stuck at Home&#x201d;: Experiences of Individuals With Amyotrophic Lateral Sclerosis Who Use Augmentative and Alternative Communication and Social Media. Am J Speech Lang Pathol. 2015;24:680&#x2013;695. doi: 10.1044/2015_AJSLP-15-0010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/2015_AJSLP-15-0010</ArticleId><ArticleId IdType="pubmed">26254447</ArticleId></ArticleIdList></Reference><Reference><Citation>Skelton K, Evans R, LaChenaye J, Amsbary J, Wingate M, Talbott L. Utilization of online focus groups to include mothers: A use-case design, reflection, and recommendations. Digit Health. 2018;4:2055207618777675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5999054</ArticleId><ArticleId IdType="pubmed">29942638</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams S, Clausen MG, Robertson A, Peacock S, McPherson K. Methodological Reflections on the Use of Asynchronous Online Focus Groups in Health Research. Int J Qual Methods. 2012;11:368&#x2013;383. doi: 10.1177/160940691201100405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/160940691201100405</ArticleId></ArticleIdList></Reference><Reference><Citation>itracks [Internet]. itracks [cited 2021 Oct 19];Available from: https://www.itracks.com/</Citation></Reference><Reference><Citation>Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277&#x2013;1288. doi: 10.1177/1049732305276687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049732305276687</ArticleId><ArticleId IdType="pubmed">16204405</ArticleId></ArticleIdList></Reference><Reference><Citation>Boogie Board&#xae; | Reusable Writing and Drawing Tablets [Internet]. Boogie Board [cited 2021 Nov 25];Available from: https://myboogieboard.com/</Citation></Reference><Reference><Citation>Bashirian S, Jenabi E, Khazaei S, Barati M, Karimi-Shahanjarini A, Zareian S, et al. Factors associated with preventive behaviours of COVID-19 among hospital staff in Iran in 2020: an application of the Protection Motivation Theory. J Hosp Infect. 2020;105:430&#x2013;433. doi: 10.1016/j.jhin.2020.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7194681</ArticleId><ArticleId IdType="pubmed">32360337</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmees R. The Role of Cognitive Appraisals and Past Protective Behavior in Future Protection Motivation: Applying Protection Motivation Theory to the COVID-19 Pandemic. 2020.</Citation></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Damme PV, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) &#x2013; revised report of an EFNS task force. Eur J Neurol. 2012;19:360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Genuis SK, Luth W, Campbell S, Bubela T, Johnston WS. Communication About End of Life for Patients Living With Amyotrophic Lateral Sclerosis: A Scoping Review of the Empirical Evidence. Front Neurol. 2021;12:1332. doi: 10.3389/fneur.2021.683197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.683197</ArticleId><ArticleId IdType="pmc">PMC8371472</ArticleId><ArticleId IdType="pubmed">34421792</ArticleId></ArticleIdList></Reference><Reference><Citation>Long R, Havics B, Zembillas M, Kelly J, Amundson M. Elucidating the End-of-Life Experience of Persons With Amyotrophic Lateral Sclerosis. [Review] Holist Nurs Pract. 2019;33:3&#x2013;8. doi: 10.1097/HNP.0000000000000301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HNP.0000000000000301</ArticleId><ArticleId IdType="pubmed">30422919</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray L, Butow PN. Advance care planning in motor neuron disease: A systematic review. Palliat Support Care. 2016;14:411&#x2013;432. doi: 10.1017/S1478951515001066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1478951515001066</ArticleId><ArticleId IdType="pubmed">26462880</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoesmith C, Abrahao A, Benstead T, Chum M, Dupre N, Izenberg A, et al. Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. CMAJ Can Med Assoc J. 2020;192:E1453&#x2013;E1468. doi: 10.1503/cmaj.191721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.191721</ArticleId><ArticleId IdType="pmc">PMC7683000</ArticleId><ArticleId IdType="pubmed">33199452</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne S, Sheeran P, Orbell S. Prediction and Intervention in Health-Related Behavior: A Meta-Analytic Review of Protection Motivation Theory. J Appl Soc Psychol. 2000;30:106&#x2013;143. doi: 10.1111/j.1559-1816.2000.tb02308.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1559-1816.2000.tb02308.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams NL, Nguyen THH, Del Chiappa G, Fedeli G, Wassler P. COVID-19 vaccine confidence and tourism at the early stage of a voluntary mass vaccination campaign: a PMT segmentation analysis. Curr Issue Tour. 2021;0:1&#x2013;15.</Citation></Reference><Reference><Citation>Kim JK, Crimmins EM. Age differences in the relationship between threatening and coping mechanisms and preventive behaviors in the time of COVID-19 in the United States: Protection Motivation Theory. Res Psychother Psychopathol Process Outcome. 2021;23:485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876510</ArticleId><ArticleId IdType="pubmed">33585294</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;uri&#x146;a S, Martinsone K, Perepjolkina V, Kolesnikova J, Vainik U, Ru&#x17e;a A, et al. Factors Related to COVID-19 Preventive Behaviors: A Structural Equation Model. Front Psychol. 2021;12:676521. doi: 10.3389/fpsyg.2021.676521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.676521</ArticleId><ArticleId IdType="pmc">PMC8288024</ArticleId><ArticleId IdType="pubmed">34290652</ArticleId></ArticleIdList></Reference><Reference><Citation>Brott T, Hocking C, Paddy A. Occupational Disruption: Living with Motor Neurone Disease. Br J Occup Ther. 2007;70:24&#x2013;31. doi: 10.1177/030802260707000107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/030802260707000107</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Addington-Hall J. How people with motor neurone disease talk about living with their illness: a narrative study. J Adv Nurs. 2008;62:200&#x2013;208. doi: 10.1111/j.1365-2648.2007.04588.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2007.04588.x</ArticleId><ArticleId IdType="pubmed">18394032</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris DA. Lived-through past, experienced present, anticipated future: Understanding &#x201c;existential loss&#x201d; in the context of life-limiting illness. Palliat Support Care. 2015;13:1579&#x2013;1594. doi: 10.1017/S1478951515000620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1478951515000620</ArticleId><ArticleId IdType="pubmed">26063467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozanne A, Graneheim UH. Understanding the incomprehensible &#x2013; patients&#x2019; and spouses&#x2019; experiences of comprehensibility before, at and after diagnosis of amyotrophic lateral sclerosis. Scand J Caring Sci. 2018;32:663&#x2013;671. doi: 10.1111/scs.12492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/scs.12492</ArticleId><ArticleId IdType="pubmed">28869647</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoun SM, Breen LJ, Howting D, Edis R, Oliver D, Henderson R, et al. Receiving the news of a diagnosis of motor neuron disease: What does it take to make it better? Amyotroph Lateral Scler Front Degener. 2016;17:168&#x2013;178. doi: 10.3109/21678421.2015.1111907.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1111907</ArticleId><ArticleId IdType="pubmed">26609553</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien MR, Whitehead B, Jack BA, Mitchell JD. From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): Experiences of people with ALS/MND and family carers &#x2013; a qualitative study. Amyotroph Lateral Scler. 2011;12:97&#x2013;104. doi: 10.3109/17482968.2010.546414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.546414</ArticleId><ArticleId IdType="pubmed">21208037</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters M, Fitzpatrick R, Doll H, Playford ED, Jenkinson C. Patients&#x2019; experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey. J Health Serv Res Policy. 2013;18:28&#x2013;33. doi: 10.1258/jhsrp.2012.011176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/jhsrp.2012.011176</ArticleId><ArticleId IdType="pubmed">23393039</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eenennaam RM, Kruithof WJ, van Es MA, Kruitwagen-van Reenen ET, Westeneng H-J, Visser-Meily JMA, et al. Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide. BMC Neurol. 2020;20:446. doi: 10.1186/s12883-020-02004-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-020-02004-8</ArticleId><ArticleId IdType="pmc">PMC7734773</ArticleId><ArticleId IdType="pubmed">33308184</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulla S, Vielhaber S, Kollewe K, Machts J, Heinze H-J, Dengler R, et al. The impact of physical impairment on emotional well-being in ALS. Amyotroph Lateral Scler Front Degener. 2014;15:392&#x2013;397. doi: 10.3109/21678421.2014.932380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.932380</ArticleId><ArticleId IdType="pubmed">25008979</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Montuschi A, Cammarosano S, Mercanti SD, Cavallo E, Ilardi A, et al. ALS patients and caregivers communication preferences and information seeking behaviour. Eur J Neurol. 2008;15:55&#x2013;60. doi: 10.1111/j.1468-1331.2008.02123.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02123.x</ArticleId><ArticleId IdType="pubmed">18005051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden A, Greenfield D, Nugus P, Kiernan MC. Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals. Patient Prefer Adher. 2012;6:691&#x2013;701. doi: 10.2147/PPA.S36759.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S36759</ArticleId><ArticleId IdType="pmc">PMC3468167</ArticleId><ArticleId IdType="pubmed">23055703</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Kim JA. Information-seeking Behavior and Information Needs in Patients With Amyotrophic Lateral Sclerosis: Analyzing an Online Patient Community. CIN Comput Inform Nurs. 2017;35:345&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">28225381</ArticleId></ArticleIdList></Reference><Reference><Citation>Mheidly N, Fares J. Leveraging media and health communication strategies to overcome the COVID-19 infodemic. J Public Health Policy. 2020;41:410&#x2013;420. doi: 10.1057/s41271-020-00247-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1057/s41271-020-00247-w</ArticleId><ArticleId IdType="pmc">PMC7441141</ArticleId><ArticleId IdType="pubmed">32826935</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangcharoensathien V, Calleja N, Nguyen T, Purnat T, D&#x2019;Agostino M, Garcia-Saiso S, et al. Framework for Managing the COVID-19 Infodemic: Methods and Results of an Online, Crowdsourced WHO Technical Consultation. J Med Internet Res. 2020;22:e19659. doi: 10.2196/19659.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/19659</ArticleId><ArticleId IdType="pmc">PMC7332158</ArticleId><ArticleId IdType="pubmed">32558655</ArticleId></ArticleIdList></Reference><Reference><Citation>Vraga EK, Bode L. Addressing COVID-19 Misinformation on Social Media Preemptively and Responsively - Volume 27, Number 2&#x2014;February 2021 - Emerging Infectious Diseases journal - CDC. Emerg Enfectious Dis. 2021;27:396&#x2013;403. doi: 10.3201/eid2702.203139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2702.203139</ArticleId><ArticleId IdType="pmc">PMC7853571</ArticleId><ArticleId IdType="pubmed">33395379</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarocostas J. How to fight an infodemic. Lancet Lond Engl. 2020;395:676. doi: 10.1016/S0140-6736(20)30461-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30461-X</ArticleId><ArticleId IdType="pmc">PMC7133615</ArticleId><ArticleId IdType="pubmed">32113495</ArticleId></ArticleIdList></Reference><Reference><Citation>Finset A, Bosworth H, Butow P, Gulbrandsen P, Hulsman RL, Pieterse AH, et al. Effective health communication &#x2013; a key factor in fighting the COVID-19 pandemic. Patient Educ Couns. 2020;103:873&#x2013;876. doi: 10.1016/j.pec.2020.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2020.03.027</ArticleId><ArticleId IdType="pmc">PMC7180027</ArticleId><ArticleId IdType="pubmed">32336348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonekar HB, Ponnaiah M. Emergence of Coronavirus (COVID-19) Outbreak: Anthropological and Social Science Perspectives. Disaster Med Public Health Prep. 2020;14:759&#x2013;761. doi: 10.1017/dmp.2020.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/dmp.2020.203</ArticleId><ArticleId IdType="pmc">PMC7385311</ArticleId><ArticleId IdType="pubmed">32576324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T. COVID-19: fighting panic with information. Lancet Lond Engl. 2020;395:537. doi: 10.1016/S0140-6736(20)30379-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30379-2</ArticleId><ArticleId IdType="pmc">PMC7138040</ArticleId><ArticleId IdType="pubmed">32087777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zullo S, Ingravallo F, Crespi V, Cascioli M, D&#x2019;Alessandro R, Gasperini M, et al. The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system&#x2019;s preparedness. Neurol Sci. 2021;42:799&#x2013;804. doi: 10.1007/s10072-020-04984-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04984-4</ArticleId><ArticleId IdType="pmc">PMC7801877</ArticleId><ArticleId IdType="pubmed">33433758</ArticleId></ArticleIdList></Reference><Reference><Citation>ALS Society of Canada. COVID-19 Update [Internet]. ALS Soc Can. 2020 [cited 2021 Nov 27];Available from: https://als.ca/blogs/covid-19-update/</Citation></Reference><Reference><Citation>ALS Society of Canada. COVID-19 vaccination: Update for the ALS community [Internet]. ALS Soc. Can. 2021 [cited 2021 Sep 14];Available from: https://www.als.ca/media-room/covid-19-vaccination-update/</Citation></Reference><Reference><Citation>MND Association. Corona virus information for people with MND. MND Assoc. 2021 [cited 2021 Sep 14];Available from: https://www.mndassociation.org/about-mnd/coronavirus-and-mnd/mnd-and-coronavirus/</Citation></Reference><Reference><Citation>D&#x2019;Alvano G, Buonanno D, Passaniti C, De Stefano M, Lavorgna L, Tedeschi G, et al. Support Needs and Interventions for Family Caregivers of Patients with Amyotrophic Lateral Sclerosis (ALS): A Narrative Review with Report of Telemedicine Experiences at the Time of COVID-19 Pandemic. Brain Sci. 2022;12:49. doi: 10.3390/brainsci12010049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12010049</ArticleId><ArticleId IdType="pmc">PMC8773661</ArticleId><ArticleId IdType="pubmed">35053794</ArticleId></ArticleIdList></Reference><Reference><Citation>Beukelman D, Fager S, Nordness A. Communication Support for People with ALS. Neurol Res Int. 2011;2011 [cited 2019 Aug 29]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096454/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3096454</ArticleId><ArticleId IdType="pubmed">21603029</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomik B, Professor RJG. Dysarthria in amyotrophic lateral sclerosis: A review. Amyotroph Lateral Scler. 2010;11:4&#x2013;15. doi: 10.3109/17482960802379004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802379004</ArticleId><ArticleId IdType="pubmed">20184513</ArticleId></ArticleIdList></Reference><Reference><Citation>Munan M, Luth W, Genuis SK, Johnston WS, MacIntyre E. Transitions in amyotrophic lateral sclerosis: patient and caregiver experiences. Can J Neurol Sci. 2021;48(4):496&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">33100231</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein S, Campanile J, Cerilli C, Gajwani P, Varadaraj V, Swenor BK. New obstacles and widening gaps: A qualitative study of the effects of the COVID-19 pandemic on U.S. adults with disabilities. Disabil Health J. 2021;14:101103. doi: 10.1016/j.dhjo.2021.101103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dhjo.2021.101103</ArticleId><ArticleId IdType="pmc">PMC9760300</ArticleId><ArticleId IdType="pubmed">33840617</ArticleId></ArticleIdList></Reference><Reference><Citation>Stough LM, Kang D. The Sendai Framework for Disaster Risk Reduction and Persons with Disabilities. Int J Disaster Risk Sci. 2015;6:140&#x2013;149. doi: 10.1007/s13753-015-0051-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13753-015-0051-8</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations Office for Disaster Risk Reduction . Sendai Framework for Disaster Risk Reduction 2015&#x2013;2030. Geneva: United Nations; 2015.</Citation></Reference><Reference><Citation>Pyke C, Wilton R. Planning for inclusion? An assessment of Ontario&#x2019;s emergency preparedness guide for people with disabilities. Int J Disaster Risk Reduct. 2020;51:101888. doi: 10.1016/j.ijdrr.2020.101888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdrr.2020.101888</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaill J, Barker RN, West C. Experiences of people with physical disabilities before, during, and after tropical cyclones in Queensland, Australia. Int J Disaster Risk Reduct. 2019;39:101122. doi: 10.1016/j.ijdrr.2019.101122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdrr.2019.101122</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Hotta M, Inuzuka T. The preparations of patients with amyotrophic lateral sclerosis for disaster after the Great East Japan earthquake. J Neurol Sci. 2017;379:304&#x2013;305. doi: 10.1016/j.jns.2017.06.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.06.035</ArticleId><ArticleId IdType="pubmed">28716267</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y. The preparations of patients with amyotrophic lateral sclerosis for natural disaster after the Great East Japan earthquake; comparison between immediately after the earthquake and 5 years later. Neurology. 2017;88 [cited 2021 Jul 29]. Available from: http://n.neurology.org/content/88/16_Supplement/P3.032.</Citation></Reference><Reference><Citation>Boyle CA, Fox MH, Havercamp SM, Zubler J. The public health response to the COVID-19 pandemic for people with disabilities. Disabil Health J. 2020;13:100943. doi: 10.1016/j.dhjo.2020.100943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dhjo.2020.100943</ArticleId><ArticleId IdType="pmc">PMC7246015</ArticleId><ArticleId IdType="pubmed">32499132</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz AE, Munsell EGS, Schmidt EK, Col&#xf3;n-Semenza C, Carolan K, Gassner DL. Impact of COVID-19 on services for people with disabilities and chronic health conditions. Disabil Health J. 2021;14:101090. doi: 10.1016/j.dhjo.2021.101090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dhjo.2021.101090</ArticleId><ArticleId IdType="pmc">PMC9760298</ArticleId><ArticleId IdType="pubmed">33715986</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett D. Five Years Later: Assessing the Implementation of the Four Priorities of the Sendai Framework for Inclusion of People with Disabilities. Int J Disaster Risk Sci. 2020;11:155&#x2013;166. doi: 10.1007/s13753-020-00267-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13753-020-00267-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering CJ, Dancey M, Paik K, O&#x2019;Sullivan T. Informal Caregiving and Disaster Risk Reduction: A Scoping Review. Int J Disaster Risk Sci. 2021;12:169&#x2013;187. doi: 10.1007/s13753-021-00328-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13753-021-00328-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam P, Villeneuve M. Advancing emergency preparedness for people with disabilities and chronic health conditions in the community: a scoping review. Disabil Rehabil. 2020;42:3256&#x2013;3264. doi: 10.1080/09638288.2019.1583781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2019.1583781</ArticleId><ArticleId IdType="pubmed">30907152</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations Office for Disaster Risk Reduction. Living with disability and disasters&#xa0;: UNISDR 2013 survey on living with disabilities and disasters&#xa0;: key findings [Internet]. Geneva, Switzerland: 2014 [cited 2021 Sep 7]. Available from: https://www.unisdr.org/2014/iddr/documents/2013DisabilitySurveryReport_030714.pdf</Citation></Reference><Reference><Citation>Anderson NH, Gluyas C, Mathers S, Hudson P, Ugalde A. &#x201c;A monster that lives in our lives&#x201d;: experiences of caregivers of people with motor neuron disease and identifying avenues for support. BMJ Support Palliat Care. 2019;9:e27.</Citation><ArticleIdList><ArticleId IdType="pubmed">27125270</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wit J, Beelen A, Drossaert CHC, Kolijn R, van den Berg LH, Visser-Meily JMA, et al. A blended psychosocial support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: protocol of a randomized controlled trial. BMC Psychol. 2018;6:20. doi: 10.1186/s40359-018-0232-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40359-018-0232-5</ArticleId><ArticleId IdType="pmc">PMC5930742</ArticleId><ArticleId IdType="pubmed">29716660</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLuca S, Papageorge N, Kalish E. The Unequal Cost of Social Distancing [Internet]. Johns Hopkins Coronavirus Resour Cent. 2021 [cited 2021 Aug 26];Available from: https://coronavirus.jhu.edu/from-our-experts/the-unequal-cost-of-social-distancing</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control . Considerations relating to social distancing measures in response to COVID-19 &#x2013; second update. Stockholm: ECDC; 2020.</Citation></Reference><Reference><Citation>King J, Edwards N, Watling H, Hair S. Barriers to disability-inclusive disaster management in the Solomon Islands: Perspectives of people with disability. Int J Disaster Risk Reduct. 2019;34:459&#x2013;466. doi: 10.1016/j.ijdrr.2018.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdrr.2018.12.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson A, Kani S. Disability-Inclusive DRR: Information, Risk and Practical-Action. In: Shaw R, Izumi T, editors. Civil Society Organization and Disaster Risk Reduction: The Asian Dilemma. Tokyo: Springer Japan; 2014. pp. 219&#x2013;236.</Citation></Reference><Reference><Citation>Marshall C, Rossman GB. Designing qualitative research. 4. Thousand Oaks: Sage Publications, Inc; 2006.</Citation></Reference><Reference><Citation>Anderson M, Perrin A. Tech adoption climbs among older adults [Internet]. Pew Research Centre; 2017 [cited 2021 Oct 18]. Available from: https://www.pewresearch.org/internet/2017/05/17/technology-use-among-seniors/</Citation></Reference><Reference><Citation>Chen-See S. Disruption of cancer care in Canada during COVID-19. Lancet Oncol. 2020;21:e374. doi: 10.1016/S1470-2045(20)30397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30397-1</ArticleId><ArticleId IdType="pmc">PMC7377791</ArticleId><ArticleId IdType="pubmed">32711682</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>